Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions
In today’s Pharmaceutical Executive Daily, new analysis outlines how EMA support programs help lower drug market entry costs, early real-world data s…
5 months, 1 week ago
Pharmaceutical Executive Daily: FDA Approves Breyanzi
In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met its primary endpoint in a …
5 months, 1 week ago
Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers
In today’s Pharmaceutical Executive Daily, former FDA commissioners caution that new vaccine policies could weaken long-established regulatory standa…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
In today’s Pharmaceutical Executive Daily, the FDA appoints Tracy Beth Høeg as acting CDER director, health systems explore new commercialization pa…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins age…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound
In today’s Pharmaceutical Executive Daily, Eli Lilly reduces the price of Zepbound single-dose vials for self-pay patients, a new report claims the F…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
In today’s Pharmaceutical Executive Daily, Novo Nordisk files for FDA approval of a higher-dose Wegovy injectable using a priority review voucher, th…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes out a $1.5 billion loan…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle
In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship Pioneering and Valo Health a…
5 months, 3 weeks ago